Stage III Prostate Cancer
Showing 26 - 49 of 49
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)
Completed
- Prostate Adenocarcinoma
- +4 more
- Degarelix
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2018
Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)
Terminated
- Adenocarcinoma of the Prostate
- +4 more
-
Seattle, WashingtonSeattle Cancer Care Alliance/University of Washington
Nov 6, 2018
Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)
Completed
- Adenocarcinoma of the Prostate
- +6 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Nov 29, 2018
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Detroit (bevacizumab, laboratory
Completed
- Adenocarcinoma of the Prostate
- +5 more
- bevacizumab
- laboratory biomarker analysis
-
Detroit, Michigan
- +1 more
Jul 1, 2018
Stage III Prostate Cancer Trial (dietary supplement, other, procedure)
Withdrawn
- Stage III Prostate Cancer
- omega-3 fatty acid
- +4 more
- (no location specified)
Jul 2, 2018
Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle (drug, genetic, other,
Completed
- Adenocarcinoma of the Prostate
- +2 more
- sorafenib tosylate
- +8 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 20, 2017
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Los Angeles, California
- +14 more
Sep 18, 2017
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage III Prostate Cancer Trial in Buffalo (dietary supplement, drug,
Terminated
- Prostate Adenocarcinoma
- +3 more
- Calcitriol
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 15, 2017
Stage III Prostate Cancer Trial in Tianjin (procedure, radiation, drug)
Unknown status
- Stage III Prostate Cancer
- Cryoablation therapy
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Hospital
Jun 9, 2017
Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle, Tacoma (drug, other,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- abiraterone acetate
- +5 more
-
Seattle, Washington
- +1 more
May 3, 2017
Prostate Adenocarcinoma, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Rochester (Bicalutamide, Flutamide, Goserelin
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Rochester, MinnesotaMayo Clinic
Apr 6, 2017
Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Orange (sunitinib malate, docetaxel,
Terminated
- Prostate Cancer
- +5 more
- sunitinib malate
- +2 more
-
Orange, CaliforniaChao Comprehensive Cancer Center
Dec 6, 2016
Prostate Adenocarcinoma, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Philadelphia (radiation, procedure,
Completed
- Prostate Adenocarcinoma
- +3 more
- Copper Cu 64 TP3805
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Ann Arbor (cilengitide)
Completed
- Recurrent Prostate Cancer
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Mar 28, 2016
Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Bicalutamide, Goserelin
Completed
- Recurrent Prostate Carcinoma
- +4 more
- Bicalutamide
- +4 more
-
Jacksonville, Florida
- +6 more
Jun 3, 2015
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer Trial in Sacramento (perifosine, laboratory
Terminated
- Adenocarcinoma of the Prostate
- +4 more
- perifosine
- laboratory biomarker analysis
-
Sacramento, CaliforniaUC Davis Cancer Center
Feb 9, 2015
Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide
Terminated
- Diarrhea
- +7 more
- cabazitaxel
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Nov 21, 2014
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Philadelphia (lapatinib ditosylate,
Completed
- Recurrent Prostate Cancer
- +4 more
- lapatinib ditosylate
- laboratory biomarker analysis
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Sep 19, 2014
Bone Metastases, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Boston (procedure, radiation, other)
Completed
- Bone Metastases
- +6 more
- magnetic resonance imaging
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 1, 2014
Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer Trial in Houston (antineoplaston A10,
Withdrawn
- Adenocarcinoma of the Prostate
- +3 more
- antineoplaston A10
- +13 more
-
Houston, TexasBurzynski Clinic
Jul 9, 2013
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial (atorvastatin calcium, )
Withdrawn
- Recurrent Prostate Cancer
- +5 more
- atorvastatin calcium
- placebo
- (no location specified)
Jun 17, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Recurrent NSCLC, Recurrent Prostate Cancer, Stage III Prostate Cancer Trial in Toronto (biological, drug, other)
Completed
- Recurrent Non-small Cell Lung Cancer
- +7 more
- GTI-2040
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jan 23, 2013